ELI LILLY & CO (LLY.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:LLY - US5324571083 - Common Stock
902.8 EUR
+13.1 (+1.47%)
Overall LLY gets a fundamental rating of 6 out of 10. We evaluated LLY against 55 industry peers in the Pharmaceuticals industry. While LLY has a great profitability rating, there are some minor concerns on its financial health. LLY is valued quite expensively, but it does show have an excellent growth rating. This makes LLY very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year LLY was profitable.
LLY had a positive operating cash flow in the past year.
LLY had positive earnings in each of the past 5 years.
LLY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of LLY (16.02%) is better than 90.91% of its industry peers.
LLY has a better Return On Equity (77.38%) than 96.36% of its industry peers.
With an excellent Return On Invested Capital value of 28.84%, LLY belongs to the best of the industry, outperforming 94.55% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LLY is significantly above the industry average of 13.65%.
The 3 year average ROIC (21.71%) for LLY is below the current ROIC(28.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
The Profit Margin of LLY (30.99%) is better than 96.36% of its industry peers.
LLY's Profit Margin has declined in the last couple of years.
LLY has a better Operating Margin (44.41%) than 96.36% of its industry peers.
In the last couple of years the Operating Margin of LLY has grown nicely.
With an excellent Gross Margin value of 83.03%, LLY belongs to the best of the industry, outperforming 85.45% of the companies in the same industry.
In the last couple of years the Gross Margin of LLY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LLY is creating value.
LLY has about the same amout of shares outstanding than it did 1 year ago.
LLY has less shares outstanding than it did 5 years ago.
The debt/assets ratio for LLY is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.28 indicates that LLY is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.28, LLY belongs to the best of the industry, outperforming 94.55% of the companies in the same industry.
LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as LLY would need 6.60 years to pay back of all of its debts.
LLY has a worse Debt to FCF ratio (6.60) than 61.82% of its industry peers.
A Debt/Equity ratio of 1.72 is on the high side and indicates that LLY has dependencies on debt financing.
LLY has a worse Debt to Equity ratio (1.72) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.28 |
ROIC/WACC3.09
WACC9.32%
2.3 Liquidity
LLY has a Current Ratio of 1.55. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.55, LLY is in line with its industry, outperforming 60.00% of the companies in the same industry.
LLY has a Quick Ratio of 1.24. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of LLY (1.24) is better than 69.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 116.22% over the past year.
The Earnings Per Share has been growing by 16.57% on average over the past years. This is quite good.
The Revenue has grown by 45.41% in the past year. This is a very strong growth!
The Revenue has been growing by 15.08% on average over the past years. This is quite good.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
3.2 Future
The Earnings Per Share is expected to grow by 31.53% on average over the next years. This is a very strong growth
Based on estimates for the next years, LLY will show a quite strong growth in Revenue. The Revenue will grow by 18.88% on average per year.
EPS Next Y84.97%
EPS Next 2Y58.86%
EPS Next 3Y46.26%
EPS Next 5Y31.53%
Revenue Next Year41.27%
Revenue Next 2Y30.36%
Revenue Next 3Y25.76%
Revenue Next 5Y18.88%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 48.25, LLY can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 65.45% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.17. LLY is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 32.34, LLY can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, LLY is valued a bit more expensive than 69.09% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LLY to the average of the S&P500 Index (23.79), we can say LLY is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.25 | ||
| Fwd PE | 32.34 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LLY is valued a bit more expensive than the industry average as 72.73% of the companies are valued more cheaply.
LLY's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. LLY is more expensive than 69.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 155.81 | ||
| EV/EBITDA | 36.09 |
4.3 Compensation for Growth
LLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LLY has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LLY's earnings are expected to grow with 46.26% in the coming years.
PEG (NY)0.57
PEG (5Y)2.91
EPS Next 2Y58.86%
EPS Next 3Y46.26%
5. Dividend
5.1 Amount
LLY has a yearly dividend return of 0.64%, which is pretty low.
LLY's Dividend Yield is comparable with the industry average which is at 1.60.
With a Dividend Yield of 0.64, LLY pays less dividend than the S&P500 average, which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
5.2 History
The dividend of LLY is nicely growing with an annual growth rate of 15.59%!
Dividend Growth(5Y)15.59%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.28% of the earnings are spent on dividend by LLY. This is a low number and sustainable payout ratio.
LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y58.86%
EPS Next 3Y46.26%
FRA:LLY (1/6/2026, 7:00:00 PM)
902.8
+13.1 (+1.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.09%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap853.49B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80.54
Price Target940.38 (4.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
Yearly Dividend4.2
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)6.76%
PT rev (3m)22.41%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)3.74%
EPS NY rev (1m)0.02%
EPS NY rev (3m)4.78%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)2.96%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)3.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.25 | ||
| Fwd PE | 32.34 | ||
| P/S | 16.88 | ||
| P/FCF | 155.81 | ||
| P/OCF | 62.44 | ||
| P/B | 42.15 | ||
| P/tB | 87.6 | ||
| EV/EBITDA | 36.09 |
EPS(TTM)18.71
EY2.07%
EPS(NY)27.92
Fwd EY3.09%
FCF(TTM)5.79
FCFY0.64%
OCF(TTM)14.46
OCFY1.6%
SpS53.49
BVpS21.42
TBVpS10.31
PEG (NY)0.57
PEG (5Y)2.91
Graham Number94.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.28 |
F-Score7
WACC9.32%
ROIC/WACC3.09
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y84.97%
EPS Next 2Y58.86%
EPS Next 3Y46.26%
EPS Next 5Y31.53%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year41.27%
Revenue Next 2Y30.36%
Revenue Next 3Y25.76%
Revenue Next 5Y18.88%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year101.98%
EBIT Next 3Y46.72%
EBIT Next 5Y32.15%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%
ELI LILLY & CO / LLY.DE FAQ
Can you provide the ChartMill fundamental rating for ELI LILLY & CO?
ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.
What is the valuation status of ELI LILLY & CO (LLY.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.
What is the profitability of LLY stock?
ELI LILLY & CO (LLY.DE) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for LLY stock?
The Price/Earnings (PE) ratio for ELI LILLY & CO (LLY.DE) is 48.25 and the Price/Book (PB) ratio is 42.15.
What is the earnings growth outlook for ELI LILLY & CO?
The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 84.97% in the next year.